Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ExeVir Bio Looks To Llamas To Tackle Coronavirus Crisis

Raises €23m From Belgium-Based Backers

Jul 28 2020

• By Kevin Grogan

Llama_Peru — Llamas produce quantities of small antibodies that can be turned into nanobodies. • Source: Shutterstock

Related Content

Coronavirus Notebook: Vaccine Pooling, WHO’s Law Lab & The Role Of The Llama

Jul 22 2020

Cablivi CHMP Backing Helps Validate Sanofi's €3.9bn Ablynx Purchase

Jun 29 2018

Related Companies

UCB S.A.

Ablynx N.V.

Sanofi

Additional Topics

Coronavirus COVID-19 Financing Clinical Trials Commercial Companies Infectious Diseases BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.